Cancer Health Treatment Update Active Cancer, Recent Chemo Linked to Higher COVID-19 Death Rates Data from a large COVID-19 and cancer registry also showed that hydroxychloroquine plus azithromycin is associated with higher mortality. Men of Color Underrepresented in Prostate Cancer Clinical Trials The proportion of Black men in these trials has decreased significantly from 1995 to 2014.  Cancer Health stands in unity with efforts across the country to fight for racial justice. Racial disparities profoundly affect cancer prevention, research, access to care and treatment, and quality of life. To read more, click here. Immunotherapy Trial in Advanced Bladder Cancer Shows Promise "Potentially practice-changing" data show patients with advanced urothelial carcinoma survive longer with immune-boosting drug after chemo. Algorithm IDs Targeted Therapy Opportunities for Kids With Cancer Use of the algorithm helped increase progression-free survival in children with poor prognosis. COVID-19 Cancer Surgery Delays Could Cost Lives British researchers crunched the numbers and saw serious cause for concern if cancer surgeries are delayed three to six months. For all of Cancer Health's coverage of the novel coronavirus and COVID-19, click here. ASCO Annual Meeting Goes Virtual See all our reports from the American Society of Clinical Oncology's virtual scientific program. Cancer Health Spring 2020 Check out our new print edition! Advertisement Newsfeed Lost Earnings from Racial Disparities in Cancer Mortality Men of Color Remain Underrepresented in Prostate Cancer Clinical Trials How One Doctor Saved His Own Life AACR Announces Recipients of the 2020 June L. Biedler Prize Blog: Food and Drug Administration (FDA) FDA Approves Qinlock for Fourth-Line Treatment of Advanced Gastrointestinal Stromal Tumors FDA Approves Tecentriq for First-Line Treatment of Metastatic Lung Cancer FDA Approves Opdivo Plus Yervoy for Lung Cancer With PD-L1 Expression FDA Approves Lynparza Plus Bevacizumab for Ovarian Cancer Maintenance Treatment Newsfeed Lost Earnings from Racial Disparities in Cancer Mortality Men of Color Remain Underrepresented in Prostate Cancer Clinical Trials How One Doctor Saved His Own Life AACR Announces Recipients of the 2020 June L. Biedler Prize Blog: Food and Drug Administration (FDA) FDA Approves Qinlock for Fourth-Line Treatment of Advanced Gastrointestinal Stromal Tumors FDA Approves Tecentriq for First-Line Treatment of Metastatic Lung Cancer FDA Approves Opdivo Plus Yervoy for Lung Cancer With PD-L1 Expression FDA Approves Lynparza Plus Bevacizumab for Ovarian Cancer Maintenance Treatment

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: